NASDAQ
Co-Diagnostics, Inc. (CODX) has a free cash flow growth of -26.17% as of Friday, May 29, 2026. This represents a 609.24% decrease compared to its 12-month average of 5.14%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.